J. Goldman & Co’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-560,900
Closed -$3.43M 841
2025
Q4
$3.43M Buy
+560,900
New +$3.35M 0.09% 250
2022
Q1
Sell
-447,500
Closed -$3.78M 429
2021
Q4
$3.78M Buy
+447,500
New +$3.86M 0.21% 132
2014
Q1
Sell
-175,000
Closed -$4.43M 285
2013
Q4
$4.43M Sell
175,000
-88,000
-33% -$2.11M 0.56% 50
2013
Q3
$5.62M Buy
+263,000
New +$5.4M 0.53% 51

Other funds holding PTEN

J. Goldman & Co's PTEN Position: Q1 2026 in Review

J. Goldman & Co reduced its Patterson-UTI (PTEN) stake by 19% in Q1 2026, selling an estimated $2.47M and leaving 1,202,375 shares worth $13M. The position accounts for 0.38% of the portfolio, ranked #74.

J. Goldman & Co first reported a position in PTEN in Q3 2013 and has held it in 8 quarters since. The position peaked at $13.5M in Q3 2014. 410 funds tracked by Wall St. Rank hold PTEN as of Q1 2026.

  • J. Goldman & Co held 1,202,375 shares of Patterson-UTI worth $13M as of Q1 2026.
  • J. Goldman & Co sold 288,850 Patterson-UTI shares in Q1 2026, an estimated $2.47M.
  • Patterson-UTI made up 0.38% of J. Goldman & Co's portfolio in Q1 2026, its #74 holding.
  • J. Goldman & Co first reported a position in Patterson-UTI in Q3 2013 and has held it in 8 quarters since.
  • J. Goldman & Co's Patterson-UTI position peaked at $13.5M in Q3 2014.
  • 410 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2026.

Based on J. Goldman & Co's 13F filing for Q1 2026, filed 15 May 2026.